These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 15496182)

  • 41. Assessing dialysis adequacy and dietary intake in the individual hemodialysis patient.
    Kloppenburg WD; Stegeman CA; Hooyschuur M; van der Ven J; de Jong PE; Huisman RM
    Kidney Int; 1999 May; 55(5):1961-9. PubMed ID: 10231460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduction in urea distribution volume over time in clinically stable dialysis patients.
    Di Filippo S; Andrulli S; Mangano S; Baragetti I; Masa A; Di Filippo G; Mura C; Nachtigal J; Baruffaldi M; Barbisoni F; Cravero R; Agliata S; Amar K; Faranna P; Locatelli F
    Kidney Int; 2006 Feb; 69(4):754-9. PubMed ID: 16518331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radionuclide method for evaluating the performance of hemodialysis in vivo.
    Bihl GR; Bird NJ; Peters C; Bradley JR; Peters AM
    Kidney Int; 2005 Feb; 67(2):721-31. PubMed ID: 15673322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short, thrice-weekly hemodialysis is inadequate regardless of small molecule clearance.
    Twardowski ZJ
    Int J Artif Organs; 2004 Jun; 27(6):452-66. PubMed ID: 15291076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of averaged concentration of urea and whole body urea clearance in prescribing the length of a dialysis session].
    Robles NR; Gonzalez-Reymundo J; Cruz A; Gomez-Ainsua C; Calderon MT; Carande J
    An Med Interna; 1996 Jan; 13(1):21-4. PubMed ID: 8679818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modeling the postdialysis rebound: the reconciliation of current formulas.
    Smye SW; Tattersall JE; Will EJ
    ASAIO J; 1999; 45(6):562-7. PubMed ID: 10593687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct calculation of KT/V. A simplified approach to monitoring of hemodialysis.
    Barth RH
    Nephron; 1988; 50(3):191-5. PubMed ID: 3226454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors determining a low dose of haemodialysis as measured by ionic dialysance in critical patients with acute kidney injury.
    Rosa-Diez G; Greloni G; Crucelegui M; Bedini-Roca M; Heredia-Martínez A; Coli ML; Giannasi S; San-Román E; Pizarro R; Belzitti C; Algranati S; Heguilen R
    Nefrologia; 2012 May; 32(3):359-66. PubMed ID: 22535160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurement of total body water and urea kinetic modelling in peritoneal dialysis.
    Woodrow G; Oldroyd B; Turney JH; Davies PS; Day JM; Smith MA
    Clin Nephrol; 1997 Jan; 47(1):52-7. PubMed ID: 9021243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences in prescribed Kt/V and delivered haemodialysis dose--why obesity makes a difference to survival for haemodialysis patients when using a 'one size fits all' Kt/V target.
    Davenport A
    Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv219-23. PubMed ID: 23787543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determination of dialysis dose: a clinical comparison of methods.
    Ahrenholz P; Taborsky P; Bohling M; Rawer P; Ibrahim N; Gajdos M; Machek P; Sagova M; Gruber H; Moucka P; Rychlik I; Leimenstoll G; Vyskocil P; Toenne G; Possnickerova J; Woggan J; Riegel W; Schneider H; Wojke R
    Blood Purif; 2011; 32(4):271-7. PubMed ID: 21860232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic renal replacement therapy in children: which index is best for adequacy?
    Verrina E; Brendolan A; Gusmano R; Ronco C
    Kidney Int; 1998 Nov; 54(5):1690-6. PubMed ID: 9844146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Kt as control and follow-up of the dose at a hemodialysis unit].
    Maduell F; Vera M; Serra N; Collado S; Carrera M; Fernández A; Arias M; Blasco M; Burgadá E; Cases A; Campistol JM
    Nefrologia; 2008; 28(1):43-7. PubMed ID: 18336130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determinants of prescribed dialysis dose and survival in a cohort of chronic hemodialysis patients.
    Iseki K; Tozawa M; Takishita S
    Clin Exp Nephrol; 2003 Sep; 7(3):231-7. PubMed ID: 14586720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors affecting survival of hemodialysis patients utilizing urea kinetic modeling. A critical appraisal of shortening dialysis times.
    Capelli JP; Kushner H; Camiscioli T; Chen SM; Stuccio-White NM
    Am J Nephrol; 1992; 12(4):212-23. PubMed ID: 1481868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increasing dialysate flow rate increases dialyzer urea clearance and dialysis efficiency: an in vivo study.
    Azar AT
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1023-9. PubMed ID: 19861865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dialysis dose and mortality in haemodialysis: is higher better?
    Béguin L; Krummel T; Longlune N; Galland R; Couchoud C; Hannedouche T
    Nephrol Dial Transplant; 2021 Dec; 36(12):2300-2307. PubMed ID: 34145896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of Kt/V and creatinine clearance with outcomes in anuric peritoneal dialysis patients.
    Fried L; Hebah N; Finkelstein F; Piraino B
    Am J Kidney Dis; 2008 Dec; 52(6):1122-30. PubMed ID: 18617306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urea modeling and Kt/V: a critical appraisal.
    Barth RH
    Kidney Int Suppl; 1993 Jun; 41():S252-60. PubMed ID: 8320932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mathematical analysis of urea rebound in long-term hemodialysis patients.
    Ookawara S; Suzuki M; Saitou M; Tabei K
    Ther Apher Dial; 2005 Apr; 9(2):167-72. PubMed ID: 15828930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.